136 related articles for article (PubMed ID: 15266677)
1. The new regulatory state: the social powers of the European Union.
Walby S
Br J Sociol; 1999 Mar; 50(1):118-40. PubMed ID: 15266677
[TBL] [Abstract][Full Text] [Related]
2. Modern regulatory impact analysis: the experience of the European Union.
Ballantine B; Devonald B
Regul Toxicol Pharmacol; 2006 Feb; 44(1):57-68. PubMed ID: 16307835
[TBL] [Abstract][Full Text] [Related]
3. Issues, and the questions they inspire, when one considers the development of European higher education for health care professionals.
Graham I
J Allied Health; 2008; 37(2):e124-39. PubMed ID: 19753391
[TBL] [Abstract][Full Text] [Related]
4. Cosmopolitan political science.
Grande E
Br J Sociol; 2006 Mar; 57(1):87-111. PubMed ID: 16506998
[TBL] [Abstract][Full Text] [Related]
5. European MEDIA Programme: the role of 'language' and 'visual images' in the processes of constructing European culture and identity.
Bozić-Vrbancić S; Vrbancić M; Orlić O
Coll Antropol; 2008 Dec; 32(4):1013-22. PubMed ID: 19149204
[TBL] [Abstract][Full Text] [Related]
6. Health impact assessment: assessing opportunities and barriers to intersectoral health improvement in an expanded European Union.
Lock K; McKee M
J Epidemiol Community Health; 2005 May; 59(5):356-60. PubMed ID: 15831682
[TBL] [Abstract][Full Text] [Related]
7. New regulatory rules for clinical trials in the United States and the European Union: key points and comparisons.
Miossec M; Miossec P
Arthritis Rheum; 2006 Dec; 54(12):3735-40. PubMed ID: 17133535
[No Abstract] [Full Text] [Related]
8. Legal aspects of E-HEALTH.
Callens S; Cierkens K
Stud Health Technol Inform; 2008; 141():47-56. PubMed ID: 18953124
[TBL] [Abstract][Full Text] [Related]
9. Healing Europe's ailing health centres in an enlarged European Union. An interview with professor Per-Gunnar Svensson. Interview by Kellie Peakman.
Svensson PG
World Hosp Health Serv; 2004; 40(2):14-5. PubMed ID: 15338992
[No Abstract] [Full Text] [Related]
10. European medical device regulation: a new era?
Donawa M
Med Device Technol; 2004 Dec; 15(10):30-1. PubMed ID: 16225282
[TBL] [Abstract][Full Text] [Related]
11. New European guidance on borderline products.
Donawa ME;
Med Device Technol; 2009 Sep; 20(5):22, 24-5. PubMed ID: 19852178
[TBL] [Abstract][Full Text] [Related]
12. [The EEC--the domestic market's social dimension].
Stallknecht K; Lunding K
Sygeplejersken; 1990 Aug; 90(32):16-7. PubMed ID: 2291173
[No Abstract] [Full Text] [Related]
13. The challenges of regulating stem cell-based products.
von Tigerstrom BJ
Trends Biotechnol; 2008 Dec; 26(12):653-8. PubMed ID: 18977047
[TBL] [Abstract][Full Text] [Related]
14. Fractured European market undermines biosimilar launches.
Moran N
Nat Biotechnol; 2008 Jan; 26(1):5-6. PubMed ID: 18183000
[No Abstract] [Full Text] [Related]
15. Opinion: EU biotech regulations stall agricultural improvements in developing countries.
Biotechnol J; 2007 Jun; 2(6):670. PubMed ID: 17570700
[No Abstract] [Full Text] [Related]
16. Impact of the European Union enlargement on health professionals and health care systems.
Avgerinos ED; Koupidis SA; Filippou DK
Health Policy; 2004 Sep; 69(3):403-8. PubMed ID: 15276318
[TBL] [Abstract][Full Text] [Related]
17. Legal and social implications of health telematics in the EU.
Dierks C
Stud Health Technol Inform; 2003; 96():143-8. PubMed ID: 15061536
[TBL] [Abstract][Full Text] [Related]
18. Health policy and European law: closing the gaps.
McKee M; Mossialos E
Public Health; 2006 Oct; 120 Suppl():16-21; discussion 21-2. PubMed ID: 16979200
[No Abstract] [Full Text] [Related]
19. Optometry and optics in Europe.
Naroo SA; Grit F
Cont Lens Anterior Eye; 2009 Jun; 32(3):101-2. PubMed ID: 19410182
[No Abstract] [Full Text] [Related]
20. Does REACH go too far?
Bowman DM; van Calster G
Nat Nanotechnol; 2007 Sep; 2(9):525-6. PubMed ID: 18654355
[No Abstract] [Full Text] [Related]
[Next] [New Search]
